{"id":39210,"date":"2022-01-22T10:52:04","date_gmt":"2022-01-22T10:52:04","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=85682"},"modified":"2022-01-22T10:52:04","modified_gmt":"2022-01-22T10:52:04","slug":"taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie","status":"publish","type":"post","link":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/","title":{"rendered":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie"},"content":{"rendered":"
\n

Le nouveau mod\u00e8le huNOG-EXL EA \u00e9tend consid\u00e9rablement les fen\u00eatres d’\u00e9tude<\/h4>\n

RENSSELAER, N.Y., 22 janv. 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, un leader mondial dans la fourniture de solutions de mod\u00e8les animaux pour la d\u00e9couverte de m\u00e9dicaments, annonce le lancement de la souris \u00e0 syst\u00e8me immunitaire humanis\u00e9 (SIH) huNOG-EXL EA (Early Access). Ce produit \u00e9tend le portefeuille largement utilis\u00e9 de Taconic. huNOG-EXL EA prolonge consid\u00e9rablement la fen\u00eatre d’\u00e9tude au cours de laquelle un mod\u00e8le de souris \u00e0 SIH avec lign\u00e9e my\u00e9lo\u00efde peut \u00eatre utilis\u00e9e avec succ\u00e8s.<\/p>\n

Les mod\u00e8les huNOG-EXL de Taconic prennent en charge les cellules my\u00e9lo\u00efdes et lympho\u00efdes humaines, ce qui rend ces souris particuli\u00e8rement utiles pour la recherche en immuno-oncologie et d’autres applications immunitaires. Avec l’allongement de la dur\u00e9e de vie de tout mod\u00e8le \u00e0 SIH soutenant les cellules my\u00e9loides, le mod\u00e8le huNOG-EXL original (d\u00e9sormais appel\u00e9 huNOG-EXL SA, ou Standard Access) est appliqu\u00e9 avec succ\u00e8s dans la recherche pr\u00e9clinique sur la d\u00e9couverte de m\u00e9dicaments depuis 2016. Le mod\u00e8le huNOG-EXL SA est fourni apr\u00e8s une \u00e9tape de contr\u00f4le qualit\u00e9 \u00e0 10 semaines apr\u00e8s la greffe. Les commentaires des utilisateurs sugg\u00e8rent que les applications de recherche n\u00e9cessitant des d\u00e9lais d’\u00e9tude particuli\u00e8rement longs ou une importation dans des r\u00e9gions avec de longues p\u00e9riodes de quarantaine pr\u00e9sentent des obstacles exp\u00e9rimentaux et logistiques qui peuvent limiter l’utilit\u00e9 du mod\u00e8le Standard Access (SA).<\/p>\n

Le nouveau mod\u00e8le huNOG-EXL EA supprime ces difficult\u00e9s en donnant acc\u00e8s aux souris dot\u00e9es du mod\u00e8le huNOG-EXL peu apr\u00e8s la greffe, ce qui \u00e9tend la fen\u00eatre d’\u00e9tude utile. Cela rend l’huNOG-EXL EA id\u00e9al pour la greffe de tumeurs \u00e0 croissance lente, pour des paradigmes de traitement plus longs ou diverses personnalisations d’\u00e9tude. Un acc\u00e8s pr\u00e9coce \u00e0 un mod\u00e8le de lign\u00e9e my\u00e9lo\u00efde \u00e9tendue est \u00e9galement avantageux pour les chercheurs confront\u00e9s \u00e0 des quarantaines d’importation de mod\u00e8les, qui autrement consommeraient une part significative de la fen\u00eatre d’\u00e9tude utile pour ces souris. Comme le mod\u00e8le huNOG-EXL EA est exp\u00e9di\u00e9 avant qu’une \u00e9tape de contr\u00f4le qualit\u00e9 de la greffe ne soit possible, il est fabriqu\u00e9 \u00e0 l’aide de cellules de donateurs pr\u00e9c\u00e9demment valid\u00e9es pour bien greffer afin de r\u00e9duire le risque de d\u00e9faillances de greffe.<\/p>\n

\u00ab\u00a0Le mod\u00e8le huNOG-EXL EA r\u00e9pond aux besoins scientifiques critiques des chercheurs qui m\u00e8nent des recherches en immuno-oncologie ou \u00e9tudient d’autres maladies immunitaires\u00a0\u00bb, a d\u00e9clar\u00e9 le Dr Michael Seiler, vice-pr\u00e9sident des produits commerciaux chez Taconic. \u00ab\u00a0Apr\u00e8s avoir men\u00e9 une recherche et un d\u00e9veloppement approfondis, ainsi que des tests b\u00eata rigoureux avec plusieurs partenaires de l’industrie, Taconic est ravie d’offrir d\u00e9sormais le nouveau mod\u00e8le et d’\u00e9tendre l’utilit\u00e9 de cette souris humanis\u00e9e unique.\u00a0\u00bb<\/p>\n

Pour en savoir plus sur le mod\u00e8le huNOG-EXL EA de Taconic, contactez Taconic au 1-888-TACONIC (888-822-6642) aux \u00c9tats-Unis, +45 70 23 04 05 en Europe ou envoyez un e-mail \u00e0 l’adresse info@taconic.com<\/a>.<\/p>\n

\u00c0 propos de Taconic Biosciences, Inc.<\/strong><\/p>\n

Taconic Biosciences est un leader mondial pleinement agr\u00e9\u00e9 dans les mod\u00e8les et les services de rongeurs g\u00e9n\u00e9tiquement modifi\u00e9s. Fond\u00e9e en 1952, la soci\u00e9t\u00e9 Taconic offre les meilleures solutions animales, afin que les clients puissent acqu\u00e9rir, g\u00e9n\u00e9rer d’une mani\u00e8re personnalis\u00e9e, \u00e9lever, pr\u00e9conditionner, tester et distribuer des mod\u00e8les de recherche pr\u00e9cieux dans le monde entier. Sp\u00e9cialiste des mod\u00e8les de souris et de rats g\u00e9n\u00e9tiquement modifi\u00e9s, du microbiome, des mod\u00e8les de souris pour l’immuno-oncologie et des services de conception de mod\u00e8les int\u00e9gr\u00e9s et d’\u00e9levage, Taconic exploite trois laboratoires de service et six \u00e9tablissements d’\u00e9levage aux \u00c9tats-Unis et en Europe, entretient des relations de distribution en Asie et dispose de capacit\u00e9s d’exp\u00e9dition mondiales pour fournir des mod\u00e8les animaux presque partout dans le monde.<\/p>\n

Contact pour les m\u00e9dias\u00a0:<\/strong><\/p>\n

Nancy J Sandy<\/p>\n

PDG<\/p>\n

608-332-6320<\/p>\n

Nancy.Sandy@taconic.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Le nouveau mod\u00e8le huNOG-EXL EA \u00e9tend consid\u00e9rablement les fen\u00eatres d\u2019\u00e9tude RENSSELAER, N.Y., 22 janv. 2022 (GLOBE NEWSWIRE) \u2014 Taconic Biosciences, un leader mondial dans la fourniture de solutions de mod\u00e8les animaux pour la d\u00e9couverte de m\u00e9dicaments, annonce le lancement de la souris \u00e0 syst\u00e8me immunitaire humanis\u00e9 (SIH) huNOG-EXL EA (Early Access). Ce produit \u00e9tend le [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[10,12],"yoast_head":"\nTaconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa\" \/>\n<meta property=\"og:description\" content=\"Le nouveau mod\u00e8le huNOG-EXL EA \u00e9tend consid\u00e9rablement les fen\u00eatres d\u2019\u00e9tude RENSSELAER, N.Y., 22 janv. 2022 (GLOBE NEWSWIRE) \u2014 Taconic Biosciences, un leader mondial dans la fourniture de solutions de mod\u00e8les animaux pour la d\u00e9couverte de m\u00e9dicaments, annonce le lancement de la souris \u00e0 syst\u00e8me immunitaire humanis\u00e9 (SIH) huNOG-EXL EA (Early Access). Ce produit \u00e9tend le [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\" \/>\n<meta property=\"og:site_name\" content=\"Times South Africa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-22T10:52:04+00:00\" \/>\n<meta name=\"author\" content=\"TSA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"TSA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\"},\"author\":{\"name\":\"TSA\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1\"},\"headline\":\"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie\",\"datePublished\":\"2022-01-22T10:52:04+00:00\",\"dateModified\":\"2022-01-22T10:52:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\"},\"wordCount\":723,\"publisher\":{\"@id\":\"https:\/\/timessouthafrica.com\/#organization\"},\"keywords\":[\"Africa\",\"South Africa\"],\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\",\"url\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\",\"name\":\"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa\",\"isPartOf\":{\"@id\":\"https:\/\/timessouthafrica.com\/#website\"},\"datePublished\":\"2022-01-22T10:52:04+00:00\",\"dateModified\":\"2022-01-22T10:52:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/timessouthafrica.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/timessouthafrica.com\/#website\",\"url\":\"https:\/\/timessouthafrica.com\/\",\"name\":\"Times South Africa\",\"description\":\"Where Africa Comes First\",\"publisher\":{\"@id\":\"https:\/\/timessouthafrica.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/timessouthafrica.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/timessouthafrica.com\/#organization\",\"name\":\"Times South Africa\",\"url\":\"https:\/\/timessouthafrica.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png\",\"contentUrl\":\"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png\",\"width\":200,\"height\":57,\"caption\":\"Times South Africa\"},\"image\":{\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1\",\"name\":\"TSA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"TSA\"},\"url\":\"https:\/\/timessouthafrica.com\/author\/tsa\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/","og_locale":"en_US","og_type":"article","og_title":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa","og_description":"Le nouveau mod\u00e8le huNOG-EXL EA \u00e9tend consid\u00e9rablement les fen\u00eatres d\u2019\u00e9tude RENSSELAER, N.Y., 22 janv. 2022 (GLOBE NEWSWIRE) \u2014 Taconic Biosciences, un leader mondial dans la fourniture de solutions de mod\u00e8les animaux pour la d\u00e9couverte de m\u00e9dicaments, annonce le lancement de la souris \u00e0 syst\u00e8me immunitaire humanis\u00e9 (SIH) huNOG-EXL EA (Early Access). Ce produit \u00e9tend le [\u2026]","og_url":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/","og_site_name":"Times South Africa","article_published_time":"2022-01-22T10:52:04+00:00","author":"TSA","twitter_card":"summary_large_image","twitter_misc":{"Written by":"TSA","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#article","isPartOf":{"@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/"},"author":{"name":"TSA","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1"},"headline":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie","datePublished":"2022-01-22T10:52:04+00:00","dateModified":"2022-01-22T10:52:04+00:00","mainEntityOfPage":{"@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/"},"wordCount":723,"publisher":{"@id":"https:\/\/timessouthafrica.com\/#organization"},"keywords":["Africa","South Africa"],"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/","url":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/","name":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie - Times South Africa","isPartOf":{"@id":"https:\/\/timessouthafrica.com\/#website"},"datePublished":"2022-01-22T10:52:04+00:00","dateModified":"2022-01-22T10:52:04+00:00","breadcrumb":{"@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/timessouthafrica.com\/taconic-biosciences-ajoute-un-nouveau-modele-de-systeme-immunitaire-humanise-sih-a-son-portefeuille-de-recherche-en-immuno-oncologie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/timessouthafrica.com\/"},{"@type":"ListItem","position":2,"name":"Taconic Biosciences ajoute un nouveau mod\u00e8le de syst\u00e8me immunitaire humanis\u00e9 (SIH) \u00e0 son portefeuille de recherche en immuno-oncologie"}]},{"@type":"WebSite","@id":"https:\/\/timessouthafrica.com\/#website","url":"https:\/\/timessouthafrica.com\/","name":"Times South Africa","description":"Where Africa Comes First","publisher":{"@id":"https:\/\/timessouthafrica.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/timessouthafrica.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/timessouthafrica.com\/#organization","name":"Times South Africa","url":"https:\/\/timessouthafrica.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/","url":"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png","contentUrl":"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png","width":200,"height":57,"caption":"Times South Africa"},"image":{"@id":"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1","name":"TSA","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"TSA"},"url":"https:\/\/timessouthafrica.com\/author\/tsa\/"}]}},"_links":{"self":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts\/39210"}],"collection":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/comments?post=39210"}],"version-history":[{"count":0,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts\/39210\/revisions"}],"wp:attachment":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/media?parent=39210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/categories?post=39210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/tags?post=39210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}